Latest news with #Ubie
Yahoo
14-05-2025
- Business
- Yahoo
WPP (LSE:WPP) Partners With Ubie And CMI To Transform DTC Healthcare Advertising
Last month, WPP experienced a 15% increase in its share price, possibly influenced by two significant developments: the announcement of a partnership with Ubie and CMI Media Group, aiming to transform direct-to-consumer advertising, and stable financial performance reported in its Q1 sales results. This rise coincided with broader market trends, where the S&P 500 and Nasdaq saw gains driven by tech sector advancements and easing U.S.-China tariff tensions. While the market's rally provided a positive backdrop, WPP's specific initiatives likely contributed additional confidence to investors amidst these favorable conditions. We've identified 1 weakness for WPP that you should be aware of. Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit. The news of WPP's recent initiatives, including the partnerships and stable Q1 sales results, potentially serves as a catalyst for enhancing investor confidence and could positively impact the company's future revenue and earnings forecasts. Such strategic alliances may drive innovation and efficiency, potentially leading to improved margins and a more robust financial outlook amid challenging market conditions. Examining a longer-term perspective, WPP's total shareholder return, including share price and dividends, was 25.49% over the past five years. This long-term performance provides context to recent movements, as the company underperformed over the last year against the UK Market return of 0.1%, but showed resilience over a broader time frame. In contrast, compared to the UK Media industry which had a return of 19.6% for the past year, WPP's performance indicates room for improvement in shorter-term investor confidence. WPP's current share price maintains a discount to the consensus analyst price target of £6.80, suggesting potential upside. Analysts expect continued focus on AI and operational efficiencies to potentially aid revenue and margin improvement. The impact of client wins such as Amazon is anticipated to contribute positively in the latter half of 2025, counteracting some of the headwinds anticipated in the first half. These enhancements can bolster earnings, aligning with projected growth figures and potentially closing the gap to the target price. As the market makes its corrections, investor attention remains on validating these initiatives' impact on revenue and earnings improvements. Assess WPP's previous results with our detailed historical performance reports. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include LSE:WPP. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
14-05-2025
- Business
- Yahoo
WPP (LSE:WPP) Partners With Ubie And CMI To Transform DTC Healthcare Advertising
Last month, WPP experienced a 15% increase in its share price, possibly influenced by two significant developments: the announcement of a partnership with Ubie and CMI Media Group, aiming to transform direct-to-consumer advertising, and stable financial performance reported in its Q1 sales results. This rise coincided with broader market trends, where the S&P 500 and Nasdaq saw gains driven by tech sector advancements and easing U.S.-China tariff tensions. While the market's rally provided a positive backdrop, WPP's specific initiatives likely contributed additional confidence to investors amidst these favorable conditions. We've identified 1 weakness for WPP that you should be aware of. Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit. The news of WPP's recent initiatives, including the partnerships and stable Q1 sales results, potentially serves as a catalyst for enhancing investor confidence and could positively impact the company's future revenue and earnings forecasts. Such strategic alliances may drive innovation and efficiency, potentially leading to improved margins and a more robust financial outlook amid challenging market conditions. Examining a longer-term perspective, WPP's total shareholder return, including share price and dividends, was 25.49% over the past five years. This long-term performance provides context to recent movements, as the company underperformed over the last year against the UK Market return of 0.1%, but showed resilience over a broader time frame. In contrast, compared to the UK Media industry which had a return of 19.6% for the past year, WPP's performance indicates room for improvement in shorter-term investor confidence. WPP's current share price maintains a discount to the consensus analyst price target of £6.80, suggesting potential upside. Analysts expect continued focus on AI and operational efficiencies to potentially aid revenue and margin improvement. The impact of client wins such as Amazon is anticipated to contribute positively in the latter half of 2025, counteracting some of the headwinds anticipated in the first half. These enhancements can bolster earnings, aligning with projected growth figures and potentially closing the gap to the target price. As the market makes its corrections, investor attention remains on validating these initiatives' impact on revenue and earnings improvements. Assess WPP's previous results with our detailed historical performance reports. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include LSE:WPP. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
13-05-2025
- Health
- Yahoo
Ubie and CMI Media Group Partner to Modernize DTC Advertising with Highly Personalized Consumer Campaigns in Women's Health, Hematology
There is a critical need for trustworthy, hyper-personalized information earlier in the diagnosis and treatment journey to empower patients to participate in their care The partnership will initially focus on endometriosis and hematology; high-need therapeutic areas where patients are actively seeking information Connecting tailored information with relevant, motivated audiences will reinvent the way DTC advertising interacts and engages with consumers NEW YORK, May 13, 2025 /PRNewswire/ -- Ubie, an AI-driven and medically vetted healthcare prediction platform that guides patients to the care they need, and CMI Media Group, a WPP (NYSE: WPP), healthcare media agency, announced a partnership aiming to transform direct-to-consumer (DTC) advertising, beginning with women's health and hematology/oncology. The collaboration integrates Ubie's AI Symptom Checker with CMI's precision media expertise to address the pharmaceutical industry's challenges in reaching patients with personalized, engaging messaging at scale. This combination will help accelerate time to diagnosis and the identification of the best available treatment. American consumers continue to face challenges in managing their own health, including long waits for doctor appointments and treatment, increasing healthcare costs, and broken patient engagement. At the same time, consumers are more active in seeking information for their health conditions, increasingly relying on online tools and information. But, there is an excessive amount of noise online, including a large amount of conflicting information and misinformation. To reach consumers, marketers need to meet patients where they are, by using highly-personalized, patient-centric, and brand-safe approaches, rather than the traditional scattergun approach – a concept understood in industries outside of healthcare. "Today's healthcare consumers are active and want to be engaged with, but with so many websites, ads, and social media posts, it can be a struggle to understand what information to trust to take control of their own care," said Kota Kubo, Co-Founder and CEO of Ubie. "By combining the ability of Ubie's medically trained AI to decode symptom patterns with CMI's strategic expertise in reaching consumers, we're creating tools that can better connect with those looking for answers about their symptoms." A one size fits all approach doesn't help patients navigate healthcare. Personalization is one key to delivering improved opportunities to engage in health behaviors. The partnership will allow DTC advertisers to engage patients individually, reaching consumers who are searching for more information where they are. Ubie's online platform is a highly accurate, medically-validated AI symptom checker that is free and easily accessible. Ubie engages patients early in their journey, providing personalized information about potential conditions and guiding them toward appropriate medical care, including appropriate providers and treatment information. This information can empower patients to become knowledgeable, active participants in their own health care and take the steps needed for better outcomes. "For this specific partnership, women's health was a perfect fit. The need for education in this space is at a critical place right now. By leveraging new technologies that allow women the opportunity to quickly and accurately gain access to data is life changing," adds Julie Hurvitz Aliaga, EVP of Innovation, Content and Partnerships of CMI Media Group. Viewing people as consumers of healthcare, rather than passive receivers, can enhance the quality of care. New innovations, like AI trained on medical data, can reach consumers with individually tailored information. DTC advertising has the opportunity to meet even the most unique needs with resources that can empower consumers to become partners in their care. About CMI Media Group CMI Media Group, a WPP company (NYSE: WPP, is a global, full-service media agency focused solely on health, wellness, and pharmaceutical marketing. CMI Media Group's core offerings include Audience Strategy, Planning, Development, and Insights; Data and Analytics; Buying and Investment; and Direct Response and Customer Experience. As the leading media resource for the world's top healthcare companies, CMI Media Group brings together leading technology, data, and talent to deliver seamless capabilities for clients. CMI Media Group has been recognized as a leader in inclusion, talent retention and employee development as well as one of the industry's best places to work. To apply for a position within our teams visit About Ubie Founded in 2017, Ubie empowers individuals and healthcare professionals with the tools they need for better care. Leveraging cutting-edge disease prediction AI, Ubie guides 10+ million patients every month to seek appropriate medical attention through its free online Symptom Checker and equips 1,900+ provider organizations with clinical tools that streamline workflows and support better diagnoses and health outcomes. Trained on medical data, Ubie's marketing solutions power advanced targeting capabilities and high-performing digital campaigns for 70% of the world's top life science companies. Learn more about our vision and work at or try our free Symptom Checker at Contact: Ryosei HatakeyamaUbie, pr@ View original content to download multimedia: SOURCE Ubie, Inc.
